| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10837450.2014.965323 |
| P698 | PubMed publication ID | 25265388 |
| P50 | author | Hossein Akbari | Q43096206 |
| P2093 | author name string | Ebrahim Saadat | |
| Fatemeh Ravar | |||
| Farid Dorkoosh | |||
| Pooya Dehghan Kelishady | |||
| P2860 | cites work | Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 |
| Therapeutic nanoparticles for drug delivery in cancer | Q28271255 | ||
| Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 | ||
| Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation | Q33182379 | ||
| Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization | Q33437962 | ||
| Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery | Q34029905 | ||
| Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions | Q34459821 | ||
| Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery | Q34783697 | ||
| Methods to assess in vitro drug release from injectable polymeric particulate systems | Q36363768 | ||
| Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores | Q36368107 | ||
| Lapatinib in breast cancer | Q36860184 | ||
| Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer | Q37113921 | ||
| Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer | Q37117151 | ||
| Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 | Q37119716 | ||
| Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases | Q37274044 | ||
| Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. | Q39254937 | ||
| Antitumor activity and molecular dynamics simulations of paclitaxel-laden triazine dendrimers | Q39409812 | ||
| Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor | Q39430827 | ||
| Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer | Q39440238 | ||
| Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. | Q39604391 | ||
| A synergistic interaction between lapatinib and chemotherapy agents in a panel of cell lines is due to the inhibition of the efflux pump BCRP. | Q39648670 | ||
| Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel. | Q39767302 | ||
| Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. | Q39789933 | ||
| Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases | Q39816322 | ||
| Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines. | Q39842390 | ||
| Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxel | Q39844935 | ||
| Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance | Q39866484 | ||
| Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines | Q40173111 | ||
| Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer | Q40209779 | ||
| Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. | Q40811036 | ||
| ABC transporters in cancer: more than just drug efflux pumps. | Q43193922 | ||
| BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents | Q43761469 | ||
| Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel | Q44668176 | ||
| Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation | Q46297662 | ||
| Pyrene absorption can be a convenient method for probing critical micellar concentration (cmc) and indexing micellar polarity | Q46660282 | ||
| Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency | Q46675585 | ||
| PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency | Q46969189 | ||
| PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. | Q51475804 | ||
| Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer. | Q54768529 | ||
| P921 | main subject | micelles | Q421110 |
| paclitaxel | Q423762 | ||
| metastatic breast cancer | Q12859063 | ||
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2014-09-29 | |
| P1433 | published in | Pharmaceutical Development and Technology | Q7180729 |
| P1476 | title | Pluronic F127 polymeric micelles for co-delivery of paclitaxel and lapatinib against metastatic breast cancer: preparation, optimization and in vitro evaluation |
| Q42094444 | Development and Validation of a Rapid RP-HPLC-DAD Analysis Method for the Simultaneous Quantitation of Paclitaxel and Lapatinib in a Polymeric Micelle Formulation |
| Q38735063 | In vitro and in vivo evaluation of paclitaxel-lapatinib-loaded F127 pluronic micelles. |
| Q38844243 | Liposomal formulation for co-delivery of paclitaxel and lapatinib, preparation, characterization and optimization |
| Q42215950 | Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier |
| Q33553597 | Redox-sensitive Pluronic F127-tocopherol micelles: synthesis, characterization, and cytotoxicity evaluation |
Search more.